Health tech journalist. Editor in Chief, pharmaphorum. Tweets are my own. Profile photos by @SOSKI_photo & @SFBIZronleuty

Joined November 2012
71 Photos and videos
Pinned Tweet
I have pretty much abandoned this platform for some time, but now I'm officially heading over to that other, cloudless one. I should be easy to find.
218
On the off-chance that this isn't muzzled, my social media coverage of #REpharmaUSA is happening elsewhere, where the skies are bluer....
163
The IRA prices are out and ... I guess the sky isn't falling? Savings for patients are significant, no one's going out of business, pharma's still not happy about the IRA. pharmaphorum.com/news/ira-ne…
1
1
1
257
I will be in Chicago this weekend for #ASCO and then San Diego next week for #BIO. My last work travel for a little while. Let me know about can't miss sessions and parties.
1
349
My liveblog coverage of FT's US Pharma and Biotech conference has begun: pharmaphorum.com/rd/ft-us-ph…
158
If you're looking to meet me out and about, the next month is your chance! I'll be at the @FT US Pharma and Biotech Summit on Thursday. Then at the end of the month I'm doing the ASCO-BIO double feature. So please reach out if you'll be in NYC, Chicago, or San Diego and say hi!
1
2
385
If your post-event survey has a free text field for a testimonial, it should also have a free text field for actual feedback.
155
One of the fun things about working at the intersection of pharma and tech is figuring out what people mean when they say "API" in any given instance. I wonder if there's anyone building APIs to manage APIs and whether working there is like Abbot and Costello routine.
1
161
Hot off the presses -- Six takeaways from JP Morgan 2024: pharmaphorum.com/market-acce…
1
1
133
Had a really great #jpm2024. I should probably have taken pictures with @naveen101, @amypuliafito, @boltyboy, and other old friends from my Mobi days. But just know it was lovely to see you all, even if briefly. Column and podcast coming soon with all my JPM-y thoughts.
3
229
. @bluebirdbio's Andrew Obenshain tells @FierceHealth 's Angus Liu that insomuch as payers are signing up for their $3.1M sickle cell drug over @VertexPharma's $2.2M alternative, they're doing it because of bluebird's outcomes-based pricing. #jpm2024
1
1
349
This strikes me as a good one to watch for value-based pricing advocates -- if it's weighting that much in payer calculations that says a lot about the power of risk-sharing.
107
I'm back for day 2 of liveblogging JPM side events. Kicked off with a great presentation from @DaiichiSankyoUS CEO Ken Keller. pharmaphorum.com/rd/jp-morga…
164
I have all but abandoned this platform, but I would love for you all to check out my JPM live blog: pharmaphorum.com/rd/jp-morga…
1
4
206
Jonah Comstock retweeted
Lucy Landman is a brave two-year-old battling the rare genetic disorder PGAP3. Her parents, Drs. Zach and Geri Landman, founded Moonshots for Unicorns in 2022 to support groundbreaking research for PGAP3 and other single gene disorders 1/
1
1
3
482
I'm at #DTXEast today and I'm liveblogging! Follow along here: pharmaphorum.com/digital/dtx…
1
1
4
282
I spent the back half of last week at @CAR_TCell in Boston, getting a crash course on the hyperevolving world of #celltherapy. I tried to compress my takeaways into one article, but look out for lots of video coverage to come. pharmaphorum.com/oncology/fi…
1
172